A systematic review and meta-analysis from the Harvard T.H. Chan School of Public Health reported a large effect of glutamatergic medications on improving symptoms of obsessive-compulsive and related disorders (OCRDs). The ...
A research team led by Harvard University has found elevated concentrations of organofluorine in U.S. municipal wastewater. More than 60% consisted of widely prescribed fluorinated pharmaceuticals, while 6 federally regulated ...
Researchers at Dana-Farber Cancer Institute collaborated with multiple institutions to pinpoint rare germline structural variants as risk factors for non-blood-related cancers in children, including tumors in various organs. ...
When we first meet another person, we typically form an initial impression of them based on their facial features and appearance. These first impressions of others could potentially influence our subsequent cognitive processes, ...
A study led by researchers from the Indiana University School of Medicine, Washington University in St. Louis, and other institutions has identified neuroanatomical differences in children associated with early substance ...
Gender differences define how the human brain ages, and telltale biomarkers in the blood may be strongly suggestive of cognitive impairment and dementia, according to a comprehensive new study involving more than 500 people.
A team of behavioral scientists at University College London has found that for long-term smokers, just one cigarette reduces lifespan by approximately 20 minutes. They have published an editorial in the journal Addiction ...
A team of medical professionals and infectious disease researchers at the University of Rochester, in New York, has found that two men who were growing their own marijuana plants died after contracting fungal lung infections ...
An Imperial College researcher with colleagues in Iran has found dose-response effects of aerobic exercise in measures of overweight and obese adults. Clinically significant improvements were observed in individuals who performed ...
A multinational study led by the LHON Study Group has revealed sustained visual improvements and a favorable safety profile five years following lenadogene nolparvovec gene therapy in patients with Leber hereditary optic ...
